Nuwellis (NUWE) announced the issuance of U.S. Patent No. 12,280,007 by the U.S. Patent and Trademark Office. The newly granted patent covers a fluid bag design that passively drains once full-reducing the need for manual intervention by clinical staff while preserving the system’s precise weight-based measurement. “Clinicians in critical care are constantly balancing precision and efficiency,” said John Erb, Interim Chief Executive Officer of Nuwellis. “This patent reflects our commitment to supporting them with smarter design – simplifying routine tasks without compromising the accuracy their patients depend on.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUWE:
- Nuwellis Highlights Strategic Shift to Critical Care
- Nuwellis, Inc. Earnings Call: Mixed Results with Promising Prospects
- Nuwellis, Inc. Reports 2024 Financial Results and Strategic Progress
- Nuwellis price target lowered to $13 from $16 at Roth MKM
- Nuwellis reports Q4 EPS (44c) vs ($54.48) last year
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue